A Phase III, Placebo-Controlled, Double-Blind, Randomized Trial Assessing the Effect of Tramiprosate on Hippocampus Volume Change in Patients with Mild-to-Moderate Alzheimer's Disease (The Alphase Study)

被引：0

作者：

Gauthier, Serge

Aisen, Paul

Ferris, Steven

Garceau, Denis

Saumier, Daniel

Duong, Anh

Sampalis, John

机构：

来源：

NEUROLOGY | 2009年 / 72卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：A246 / A247

页数：2

共 50 条

[21] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. Scott
Thomas, Ronald G.
Craft, Suzanne
van Dyck, Christopher H.
Mintzer, Jacobo
Reynolds, Brigid A.
Brewer, James B.
Rissman, Robert A.
Raman, Rema
Aisen, Paul S.
NEUROLOGY, 2015, 85 (16) : 1383 - 1391
[22] A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
Ruether, E
Husmann, R
Kinzler, E
Diabl, E
Klingler, D
Spatt, J
Ritter, R
Schmidt, R
Taneri, Z
Winterer, W
Koper, D
Kasper, S
Rainer, M
Moessler, H
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 253 - 263
[23] Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
Dubee, Vincent
Roy, Pierre-Marie
Vielle, Bruno
Parot-Schinkel, Elsa
Blanchet, Odile
Darsonval, Astrid
Lefeuvre, Caroline
Abbara, Chadi
Boucher, Sophie
Devaud, Edouard
Robineau, Olivier
Rispal, Patrick
Guimard, Thomas
d'Anglejean, Emma
Diamantis, Sylvain
Custaud, Marc-Antoine
Pellier, Isabelle
Mercat, Alain
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1124 - 1130
[24] Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial
Jafari, S.
Ashrafizadeh, S. -G.
Zeinoddini, A.
Rasoulinejad, M.
Entezari, P.
Seddighi, S.
Akhondzadeh, S.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (04) : 441 - 446
[25] Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
Nave, Stephane
Doody, Rachelle S.
Boada, Merce
Grimmer, Timo
Savola, Juha-Matti
Delmar, Paul
Pauly-Evers, Meike
Nikolcheva, Tania
Czech, Christian
Borroni, Edilio
Ricci, Benedicte
Dukart, Juergen
Mannino, Marie
Carey, Tracie
Moran, Emma
Gilaberte, Inma
Muelhardt, Nicoletta Milani
Gerlach, Irene
Santarelli, Luca
Ostrowitzki, Susanne
Fontoura, Paulo
JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1217 - 1228
[26] A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: The malt study
Dubois, B
McKeith, I
Orgogozo, JM
Collins, O
Meulien, D
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 14 (11) : 973 - 982
[27] Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma - A randomized, double-blind, placebo-controlled trial
Suissa, S
Dennis, R
Ernst, P
Sheehy, O
WoodDauphinee, S
ANNALS OF INTERNAL MEDICINE, 1997, 126 (03) : 177 - +
[28] Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Dubois, Bruno
Lopez-Arrieta, Jesus
Lipschitz, Stanley
Triantafyllos, Doskas
Spiru, Luiza
Moroz, Svitlana
Venger, Olena
Vermersch, Patrick
Moussy, Alain
Mansfield, Colin D. D.
Hermine, Olivier
Tsolaki, Magda
ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
[29] Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis
Patel, H
Gouin, S
Platt, RW
JOURNAL OF PEDIATRICS, 2003, 142 (05): : 509 - 514
[30] Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: A randomized, double-blind, placebo-controlled trial
Mozaffari-Khosravi, Hassan
Yassini-Ardakani, Mojtaba
Karamati, Mohsen
Shariati-Bafghi, Seyedeh-Elaheh
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (07) : 636 - 644

← 1 2 3 4 5 →